TABLE 2.
Test | Sensitivity (%) | Specificity (%) | Reference(s) |
---|---|---|---|
Nonspecific CSF biomarkers | |||
14-3-3 | 61–95 | 40–92 | 16–18 |
t-tau | 87–90 | 67–75 | 16, 18 |
t-tau/p-tau ratio | 94 | 86 | 18 |
NSE | 80 | 83–92 | 18, 20–22 |
S100B | |||
sCJD | 94 | 85 | 22 |
vCJD | 78 | 76 | 26 |
gCJD | 20–92 | 27 | |
Alpha-synuclein | 93–98 | 96–97 | 28–30 |
Specific biomarkers | |||
CSF RT-QuIC (2nd generation) | 92–97.2 | 98.5–100 | 34, 35 |
Brain biopsy PrPSc Western blotting | 20–60 | 39 |